A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

Irene M. Ghobrial, Nikhil C. Munshi, Brianna N. Harris, Peipei Shi, Nichole M. Porter, Robert L. Schlossman, Jacob P. Laubach, Kenneth C. Anderson, Durisala Desaiah, Scott P. Myrand, James E. Wooldridge, Paul G. Richardson, Rafat Abonour

Research output: Contribution to journalArticle

22 Scopus citations

Fingerprint Dive into the research topics of 'A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences